Treatments and Outcomes in Neuroendocrine Patients Treated with Long-Acting Somatostatin Analogues: An Italian Real-World Propensity Score-Matched Cohort Study

Treatments and Outcomes in Neuroendocrine Patients Treated with Long-Acting Somatostatin Analogues: An Italian Real-World Propensity Score-Matched Cohort Study

<b>Objectives</b>: The aim of this study was to investigate the treatment patterns and outcomes in two propensity score-matched cohorts of patients with neuroendocrine tumours (NETs) treated with first-line somatostatin analogue (SSA). <b>Methods</b>: Metastatic NET patients...

Full description

Bibliographic Details
Main Authors: Nicoletta Ranallo, Andrea Roncadori, Nicola Gentili, William Balzi, Mattia Altini, Virginia Ghini, Roberta Maltoni, Alice Andalò, Martina Cavallucci, Maddalena Sansovini, Valentina Fausti, Maria Teresa Montella, Ilaria Massa, Valentina Danesi
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Biomedicines
Subjects:
neuroendocrine tumour (NET)
real-world evidence
somatostatin analogue (SSA)
lanreotide
octreotide
propensity score matching (PSM)
Online Access:https://www.mdpi.com/2227-9059/13/2/515

Internet

https://www.mdpi.com/2227-9059/13/2/515

Similar Items